Keenan Greg reported AUPH

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002044006-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Feb 2, 2026

Published

Feb 3, 2026

Ingested by INSIDER

Nov 5, 04:19 UTC

Last re-read

Nov 5, 04:19 UTC

Extracted facts

Filer

Keenan Greg

Role

SVP, Chief Medical Officer

Transaction

Tax withholdingAs filed: “F”

Asset

Aurinia Pharmaceuticals Inc.

Ticker

AUPH

Shares

11.6K

Price per share

$14.53

Value

$167,851

Execution date (reported)

Feb 2, 2026

Owned after transaction

121.9K shares

Days from execution to publication

1

Calculation

What this establishes

Keenan Greg filed this Form 4 reporting a tax withholding of AUPH on Feb 2, 2026. It became public on Feb 3, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

SVP, Chief Medical Officer

Keenan Gregcik:0002044006

Issuer

Aurinia Pharmaceuticals Inc.cik:0001600620

Revision history · 0

No field has changed since this record was first ingested.